title: Appendicovesical Fistula Following Transurethral Resection of Bladder Tumor With Mitomycin C.
abstract: Appendicovesical fistula is a rare entity, with only 116 cases reported to date. It is an uncommon form of enterovesical fistula and often associated with a history of appendicitis. It can present as pneumaturia, fecaluria, and recurrent urinary tract infections, not unlike symptoms of enterovesical fistulas. We present a novel case of appendicovesical fistula developing after transurethral resection of bladder tumor and instillation of mitomycin C. Treatment included laparoscopic appendectomy and bladder repair.
authors.affiliation: Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: Tom.feng@cshs.org.
authors.forename: Tom S
authors.initials: TS
authors.lastname: Feng
authors.affiliation: Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA.
authors.forename: Susan
authors.initials: S
authors.lastname: Rusnack
authors.affiliation: Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
authors.forename: Jan
authors.initials: J
authors.lastname: Kaminski
authors.affiliation: Division of Colorectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
authors.forename: Phillip
authors.initials: P
authors.lastname: Fleshner
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001065:Appendix; D002429:Cecal Diseases / Q000209:etiology*; D015653:Cystectomy / Q000009:adverse effects*; D006801:Humans; D007412:Intestinal Fistula / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects*; D001747:Urinary Bladder Fistula / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D016685:Mitomycin